Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K V Giriraja

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 13, 2023
Response to Letter to EditorK V Giriraja, S K Bhanagar, L Tomlinson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 30, 2023
An open-label, multicenter, phase 2 study of a food enriched with docosahexaenoic acid in adults with sickle cell diseaseK V Giriraja, S K Bhatnagar, L Tomlinson, et al.
Diagnostics (Basel, Switzerland)|May 23, 2020
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable DiseasesK V Giriraja, Suman Govindaraj, H P Chandrakumar, et al.
JAMA Network Open|May 15, 2023
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical TrialAshu Rastogi, Sudhir A Kulkarni, Sanjay Agarwal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 13, 2023
Response to Letter to EditorK V Giriraja, S K Bhanagar, L Tomlinson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 30, 2023
An open-label, multicenter, phase 2 study of a food enriched with docosahexaenoic acid in adults with sickle cell diseaseK V Giriraja, S K Bhatnagar, L Tomlinson, et al.
Diagnostics (Basel, Switzerland)|May 23, 2020
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable DiseasesK V Giriraja, Suman Govindaraj, H P Chandrakumar, et al.
JAMA Network Open|May 15, 2023
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical TrialAshu Rastogi, Sudhir A Kulkarni, Sanjay Agarwal, et al.
Pageof 1